Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
3.470
+0.060 (1.76%)
At close: Feb 21, 2025, 4:00 PM
3.310
-0.160 (-4.61%)
After-hours: Feb 21, 2025, 5:57 PM EST
Aptevo Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 8.71 | 16.9 | 22.64 | 45.04 | 39.98 | Upgrade
|
| Cash & Short-Term Investments | 8.71 | 16.9 | 22.64 | 45.04 | 39.98 | Upgrade
|
| Cash Growth | -48.45% | -25.32% | -49.75% | 12.67% | 221.17% | Upgrade
|
| Accounts Receivable | - | - | 2.5 | 3.66 | 2.37 | Upgrade
|
| Receivables | - | - | 2.5 | 3.66 | 2.37 | Upgrade
|
| Prepaid Expenses | 1.69 | 1.47 | 1.57 | 1.82 | 2.23 | Upgrade
|
| Restricted Cash | - | - | - | 1.26 | 2.56 | Upgrade
|
| Other Current Assets | 0.26 | 0.69 | 0.74 | 0.78 | 0.13 | Upgrade
|
| Total Current Assets | 10.66 | 19.07 | 27.45 | 52.57 | 47.26 | Upgrade
|
| Property, Plant & Equipment | 4.93 | 5.78 | 6.77 | 3.96 | 5.54 | Upgrade
|
| Other Long-Term Assets | - | - | - | 0.07 | 0.75 | Upgrade
|
| Total Assets | 15.59 | 24.84 | 34.22 | 56.6 | 53.55 | Upgrade
|
| Accounts Payable | 3.05 | 3.98 | 3.5 | 3.46 | 5.58 | Upgrade
|
| Accrued Expenses | 1.86 | 2.1 | 2.11 | 2.08 | 2.76 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | 2 | 11.67 | 5 | Upgrade
|
| Current Portion of Leases | 0.77 | - | 0.42 | - | - | Upgrade
|
| Current Unearned Revenue | - | - | - | 15.47 | - | Upgrade
|
| Other Current Liabilities | 0.53 | 1.14 | 0.68 | 2.09 | 1.2 | Upgrade
|
| Total Current Liabilities | 6.21 | 7.22 | 8.71 | 34.76 | 14.54 | Upgrade
|
| Long-Term Debt | - | - | 1.46 | 3.71 | 20.05 | Upgrade
|
| Long-Term Leases | 4.63 | 5.4 | 6.08 | 1.34 | 2.36 | Upgrade
|
| Long-Term Unearned Revenue | - | - | - | 15.58 | - | Upgrade
|
| Total Liabilities | 10.84 | 12.62 | 16.24 | 55.39 | 36.95 | Upgrade
|
| Common Stock | 0.08 | 0.06 | 0.05 | 0.05 | 0.05 | Upgrade
|
| Additional Paid-In Capital | 252.25 | 235.61 | 223.96 | 215.23 | 202.15 | Upgrade
|
| Retained Earnings | -247.58 | -223.45 | -206.04 | -214.06 | -185.61 | Upgrade
|
| Shareholders' Equity | 4.76 | 12.22 | 17.97 | 1.22 | 16.59 | Upgrade
|
| Total Liabilities & Equity | 15.59 | 24.84 | 34.22 | 56.6 | 53.55 | Upgrade
|
| Total Debt | 5.4 | 5.4 | 9.96 | 16.72 | 27.41 | Upgrade
|
| Net Cash (Debt) | 3.32 | 11.51 | 12.68 | 28.33 | 12.57 | Upgrade
|
| Net Cash Growth | -71.18% | -9.24% | -55.24% | 125.46% | - | Upgrade
|
| Net Cash Per Share | 12.01 | - | - | - | - | Upgrade
|
| Filing Date Shares Outstanding | 1.46 | 0.01 | - | - | - | Upgrade
|
| Total Common Shares Outstanding | 1.46 | 0.01 | - | - | - | Upgrade
|
| Working Capital | 4.45 | 11.84 | 18.74 | 17.81 | 32.73 | Upgrade
|
| Book Value Per Share | 3.26 | 1021.99 | - | - | - | Upgrade
|
| Tangible Book Value | 4.76 | 12.22 | 17.97 | 1.22 | 16.59 | Upgrade
|
| Tangible Book Value Per Share | 3.26 | 1021.99 | - | - | - | Upgrade
|
| Machinery | 12.26 | 12.26 | 12.26 | 12.43 | 11.73 | Upgrade
|
| Leasehold Improvements | 2.23 | 2.23 | 2.23 | 2.23 | 2.23 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.